ENGN · enGene Therapeutics Inc.
$1.78
+0.01 (+0.56%)
At close · Aug 21
Market Cap
$119.24M
Shares
66.99M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 8-K | 2026-07-17 | — | |
| 8-K | 2026-07-16 | 2026-07-15 | |
| 8-K/A | 2026-06-18 | 2026-06-16 | |
| 10-Q | 2026-06-15 | 2026-04-30 | |
| 8-K | 2026-06-15 | 2026-06-13 | |
| 8-K | 2026-06-10 | 2026-06-09 | |
| DEF 14A | 2026-05-08 | 2026-06-09 | |
| 8-K | 2026-05-07 | 2026-05-05 | |
| 8-K | 2026-04-09 | 2026-04-07 | |
| 8-K | 2026-03-09 | — | |
| 10-Q | 2026-03-09 | 2026-01-31 | |
| 8-K | 2026-03-09 | — | |
| 10-K/A | 2026-02-19 | 2025-10-31 | |
| 8-K | 2026-01-21 | 2026-01-20 | |
| 8-K | 2026-01-21 | 2026-01-20 | |
| 10-K | 2025-12-22 | 2025-10-31 | |
| 8-K | 2025-12-22 | — | |
| 8-K | 2025-11-14 | 2025-11-12 | |
| 8-K | 2025-11-12 | 2025-11-11 | |
| 8-K | 2025-10-02 | — | |
| 8-K/A | 2025-10-02 | 2025-07-07 | |
| 8-K | 2025-09-30 | — | |
| 10-Q | 2025-09-11 | 2025-07-31 | |
| 8-K | 2025-09-11 | — | |
| 8-K | 2025-09-03 | — | |
| 8-K | 2025-07-08 | 2025-07-07 | |
| 10-Q | 2025-06-12 | 2025-04-30 | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-06-09 | 2025-06-04 | |
| 8-K | 2025-06-04 | 2025-06-03 | |
| DEF 14A | 2025-05-09 | 2025-06-10 | |
| 10-Q | 2025-03-10 | 2025-01-31 | |
| 8-K | 2025-03-10 | — | |
| 10-K/A | 2025-02-20 | 2024-10-31 | |
| 8-K | 2024-12-20 | — | |
| 10-K | 2024-12-19 | 2024-10-31 | |
| 8-K | 2024-12-19 | — | |
| 8-K | 2024-10-25 | 2024-10-24 | |
| 8-K | 2024-10-21 | 2024-10-16 | |
| 8-K | 2024-09-26 | — | |
| 8-K | 2024-09-10 | — | |
| 10-Q | 2024-09-10 | 2024-07-31 | |
| 8-K | 2024-09-05 | — | |
| 8-K | 2024-07-24 | 2024-07-22 | |
| 10-Q | 2024-06-14 | 2024-04-30 | |
| 8-K | 2024-06-14 | — | |
| 8-K | 2024-05-15 | — | |
| DEF 14A | 2024-04-18 | 2024-05-15 |
Showing 1–50 of 61 filings